GCM
SANA icon

Graham Capital Management’s Sana Biotechnology SANA Stock Holding History

Graham Capital Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-44,570
Closed -$158K – 1549
2025
Q3 		$158K Buy
+44,570
New +$161K ﹤0.01% 1103
2024
Q4 		– Sell
-21,588
Closed -$89.8K – 1454
2024
Q3 		$89.8K Sell
21,588
-75,288
-78% -$396K ﹤0.01% 1014
2024
Q2 		$529K Buy
+96,876
New +$772K 0.01% 572
2023
Q4 		– Sell
-19,861
Closed -$76.9K – 1292
2023
Q3 		$76.9K Buy
+19,861
New +$107K ﹤0.01% 943

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Graham Capital Management's SANA Position: Q4 2025 in Review

Graham Capital Management sold out of Sana Biotechnology (SANA) in Q4 2025, closing a stake of 44,570 shares — an estimated $158K sold.

Graham Capital Management first reported a position in SANA in Q3 2023 and held it in 4 quarters. The position peaked at $529K in Q2 2024. 203 funds tracked by Wall St. Rank hold SANA as of Q4 2025.

  • Graham Capital Management reported no remaining Sana Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Graham Capital Management sold 44,570 Sana Biotechnology shares in Q4 2025, an estimated $158K.
  • Graham Capital Management first reported a position in Sana Biotechnology in Q3 2023 and held it in 4 quarters.
  • Graham Capital Management's Sana Biotechnology position peaked at $529K in Q2 2024.
  • 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.